RecruitingPHASE1, PHASE2NCT07304843
A Two-part Study to Investigate the Effects in Adults of Two Doses of Golexanolone in Patients With Primary Biliary Cholangitis (PBC) With Fatigue and Cognitive Dysfunction
Studying Primary biliary cholangitis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Umecrine Cognition AB
- Principal Investigator
- Pernilla SandwallUmecrine Cognition
- Intervention
- golexanolone(drug)
- Enrollment
- 84 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2023 – 2026
Study locations (30)
- University Hospital Düsseldorf, Düsseldorf, Germany
- University of Leipzig, Leipzig, Germany
- Hippokration General Hospital of Athens, Athens, Greece
- University Hospital of Patras, Pátrai, Greece
- Bekes County Central Hospital, Gyula, Hungary
- Facility of CRU Hungary Ltd., Kistarcsa, Hungary
- Università di Milano-Bicocca, S.C. ASST Grande Ospedale Metropolitano Niguarda, Dipartimento di Medicina e Chirurgia, Epatologia e Gastroenterologia, Milan, Italy
- Fondazione IRCCS San Gerardo dei Tintori, Autoimmune Liver Disease Centre, ERN-Rare Liver, Department of Medicine and Surgery, Division of Gastroenterology, Monza, Italy
- University of Padova, Department of Surgery, Oncology and Gastroenterology, Padua, Italy
- University Hospital Paolo Giaccone, University of Palermo, Palermo, Italy
- A. Gemelli Polyclinic, Sacro Cuore Catholic University, Roma, Italy
- Humanitas University, Rozzano, Italy
- University of Udine, Udine, Italy
- University Medical Center "Zvezdara", Belgrade, Serbia
- Hospital Universitario Parc Taulí, Barcelona, Spain
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07304843 on ClinicalTrials.govOther trials for Primary biliary cholangitis
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07449793Biochemical Response and Clinical Outcomes in Patients With PBCRenJi Hospital
- RECRUITINGPHASE3NCT07296458FIREFLY Trial: Fenofibrate Intervention---Randomized Evaluation in First-Line PBC TherapyXijing Hospital of Digestive Diseases
- RECRUITINGPHASE3NCT07282353A Study of CS0159 in Patients With PBC With Inadequate Response or Intolerance to UDCACascade Pharmaceuticals, Inc
- RECRUITINGNCT07205874Early Diagnosis of Primary Biliary Cholangitis (PBC) in Patients With Positive Anti-Mitochondrial Antibodies (AMA) and Normal Alkaline Phosphatase (ALP)Hospital Universitario La Paz
- ACTIVE NOT RECRUITINGNCT07049887A Study Describing Scratch and Sleep Patterns in Patients With Primary Biliary Cholangitis (Luminaria)Ipsen
- RECRUITINGNCT07149675PBC Long-term Outcomes StudyBeijing Friendship Hospital
- RECRUITINGEARLY PHASE1NCT07104201Fenofibrate in Subjects With Primary Biliary Cholangitis (PBC)Xijing Hospital of Digestive Diseases
- RECRUITINGNANCT06861465EMPower MechanismsUniversity of Alberta